Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06045962 · ClinicalTrials.gov registry record · NA
Optimal Stent Duration After Ureteroscopy
A NA study, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT06045962: Active NA study, sponsored by Mayo Clinic.
NCT06045962 is a NA study that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06045962, a NA study, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
Primary Outcome
The urinary symptoms will be assessed using the self-reported Canadian Endourology Group Stent Symptom Score. Seven item questionnaire to assess urinary stent symptoms using a 5-point Likert scale; higher score indicated worse outcome.
Interventions
- DEVICE Ureteral stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What the registry record for NCT06045962 still lists
NCT06045962 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Ureteral stent is the first listed.
NCT06045962 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06045962 about?
NCT06045962 is a clinical study titled "Optimal Stent Duration After Ureteroscopy". The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
What is the current status of trial NCT06045962?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2023-11-01. Estimated completion is 2026-09-01.
What interventions are being tested in trial NCT06045962?
The interventions under investigation include: Ureteral stent (DEVICE).
Who is sponsoring clinical trial NCT06045962?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06045962's enrollment target sits among peer trials
172 612th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI